Verrica Pharmaceuticals Inc. Expense Breakdown
No Expense Breakdown for VRCA on this site yet.
- 2026-06-30: Reportable $443.00K.
- 2025-06-30: Reportable $154.00K.
Source checked: the stored Expense Breakdown page for VRCA.
Expenses by product
Cost Of License And Collaboration Revenue: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $443.00K |
|---|
| 2025-06-30 | $154.00K |
|---|
Cost Of Product Revenue: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $435.00K |
|---|
| 2025-06-30 | $340.00K |
|---|
Research and development: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $6.03M |
|---|
| 2025-06-30 | $1.85M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $10.35M |
|---|
| 2025-06-30 | $8.85M |
|---|